Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519501 · ClinicalTrials.gov registry record · NA
Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers
A NA study, sponsored by Syntr Health Technologies.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05519501 is a NA study that has completed, run by Syntr Health Technologies. The registered enrollment target is 16 participants.
The verdict
NCT05519501, a NA study, has completed, sponsored by Syntr Health Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a randomized controlled multi center study on diabetic patients with the aim of evaluating the efficacy of the adipose tissue processed with the SyntrFuge™ system in diabetic patients with diabetic foot ulcers. In particular, it will be evaluated whether the microsized fat graft will be able to shorten the healing times of these wounds. Patients will be randomized to the treatment group with adipose tissue processed with the SyntrFuge™ system (injection of autologous microsized adipose tissue) or to the control group represented by the standard of care.
Interventions
- PROCEDURE Standard of Care
- DEVICE SyntrFuge System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-10-10 |
| Est. Completion | 2024-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05519501
The ClinicalTrials.gov registry entry for NCT05519501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syntr Health Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05519501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05519501 about?
NCT05519501 is a clinical study titled "Randomized Controlled Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers". This is a randomized controlled multi center study on diabetic patients with the aim of evaluating the efficacy of the adipose tissue processed with the SyntrFuge™ system in diabetic patients with diabetic foot ulcers. In particular, it will be evaluated whether the microsized fat graft will be able...
What is the current status of trial NCT05519501?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-10-10. Estimated completion is 2024-08-09.
What interventions are being tested in trial NCT05519501?
The interventions under investigation include: Standard of Care (PROCEDURE), SyntrFuge System (DEVICE).
Who is sponsoring clinical trial NCT05519501?
This trial is sponsored by Syntr Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.